Home›Lutetium Lu 177 Dotatate›Lutetium Lu 177 Dotatate + Octreotide Acetate

Does Lutetium Lu 177 Dotatate Interact with Octreotide Acetate?

Lutetium Lu 177 Dotatate and Octreotide Acetate have a contraindicated drug interaction according to U.S. FDA drug labeling data. Octreotide competitively binds somatostatin receptors and may interfere with lutetium Lu 177 dotatate efficacy. Discontinue octreotide at least 24 hours prior to each lutetium dose. The mechanism involves competitive binding to somatostatin receptors. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Contraindicated
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Lutetium Lu 177 Dotatate and Octreotide Acetate occurs because competitive binding to somatostatin receptors. Clinically, this means octreotide competitively binds somatostatin receptors and may interfere with lutetium lu 177 dotatate efficacy. discontinue octreotide at least 24 hours prior to each lutetium dose. Because of the severity of this interaction, these medications are contraindicated — meaning they should not be taken together under any circumstances. If you are currently taking both, contact your healthcare provider immediately to discuss alternatives.

What To Tell Your Doctor or Pharmacist

If you are taking Lutetium Lu 177 Dotatate and your doctor is considering prescribing Octreotide Acetate (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Lutetium Lu 177 Dotatate(Lutathera)+💊 Octreotide Acetate(Octreotide Acetate)

Severity & Interaction Details

⛔
contraindicated
Avoid this combination
FDA labeling lists this pair as contraindicated. The risk outweighs the benefit in nearly all cases.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
—
Source
NLP:octreotide acetate

What this means in plain English

Octreotide competitively binds somatostatin receptors and may interfere with lutetium Lu 177 dotatate efficacy. Discontinue octreotide at least 24 hours prior to each lutetium dose.

What the FDA label says

"Competitive binding to somatostatin receptors"

📖 Source: NLP:octreotide acetate

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Lutetium Lu 177 Dotatate and Octreotide Acetate against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.